Sapient Therapeutics is a biopharmaceutical firm dedicated to advancing neuroscience drug discovery and early clinical development. Our primary candidate, SAP021, is currently undergoing Phase 1 studies with an anticipated completion in 2023. Our leadership team consists of seasoned experts in neuroscience and cannabinoid medicine. Collaboratively, we leverage our extensive experience in cannabinoid development to introduce no...
Sapient Therapeutics is a biopharmaceutical firm dedicated to advancing neuroscience drug discovery and early clinical development. Our primary candidate, SAP021, is currently undergoing Phase 1 studies with an anticipated completion in 2023. Our leadership team consists of seasoned experts in neuroscience and cannabinoid medicine. Collaboratively, we leverage our extensive experience in cannabinoid development to introduce novel prescription medicines aimed at providing relief to patients grappling with severe diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.